| Drug Name: | Peginterferon Alfa-2B (215647-85-1) |
|---|---|
| PubChem ID: | |
| SMILES: | |
| InchiKey: | |
| Therapeutic Category: | Anti-Infective Agents, Antiviral Agents |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Thalidomide (50-35-1) | Bone Marrow Depression | Additive | severe suppression in this patient may have been due to the combined effects of the peginterferon and thalidomide | Thalidomide in Advanced Hepatocellular Carcinoma with Optional Low-Dose Interferon-?2a upon Progression |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|